BridgeBio Pharma BBIO
NASDAQ BBIO
$67.55 -0.39 (-0.57%)
At close: Oct 20, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Finished Goods (2025 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Finished Goods of $11.12 million for Q2 2026, up 93.4% from $5.75 million a year earlier and up 38.3% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Finished Goods (2025 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma posted Finished Goods of $6.51 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $8.04 million (Q1 2026), $6.51 million (Q4 2025) and $4.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 BridgeBio Pharma 13.20 Bn 10.31 Bn 228.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.12 Mn
Mar 31, 2026 8.04 Mn
Dec 31, 2025 6.51 Mn
Sep 30, 2025 4.97 Mn
Jun 30, 2025 5.75 Mn
Mar 31, 2025 2.64 Mn
API Access

BridgeBio Pharma Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=BBIO&period=max&api_key=YOUR_API_KEY